In a separate study, CureVac has explored an analysis on castrate-resistant prostate cancer patients using protamine-complexed mRNA encoding for prostate-specific membrane antigen (PSMA), prostate-specific antigen (PSA), six transmembrane epithelial antigen of the prostate 1 (STEAP1), and prostate stem cell antigen (PSCA) [65]. This evidence concerns the gene PSCA and prostate carcinoma.